Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

KORU Medical Systems (KRMD) Long-Term Deferred Tax (2020 - 2024)

Historic Long-Term Deferred Tax for KORU Medical Systems (KRMD) over the last 5 years, with Q4 2024 value amounting to $8.3 million.

  • KORU Medical Systems' Long-Term Deferred Tax rose 1998.29% to $8.3 million in Q4 2024 from the same period last year, while for Dec 2024 it was $8.3 million, marking a year-over-year increase of 1998.29%. This contributed to the annual value of $8.3 million for FY2024, which is 1998.29% up from last year.
  • KORU Medical Systems' Long-Term Deferred Tax amounted to $8.3 million in Q4 2024, which was up 1998.29% from $6.9 million recorded in Q4 2023.
  • In the past 5 years, KORU Medical Systems' Long-Term Deferred Tax registered a high of $8.3 million during Q4 2024, and its lowest value of $125274.0 during Q4 2020.
  • Its 5-year average for Long-Term Deferred Tax is $3.5 million, with a median of $3.4 million in 2022.
  • As far as peak fluctuations go, KORU Medical Systems' Long-Term Deferred Tax skyrocketed by 144960.65% in 2021, and later soared by 1998.29% in 2024.
  • Over the past 5 years, KORU Medical Systems' Long-Term Deferred Tax (Quarter) stood at $125274.0 in 2020, then skyrocketed by 1449.61% to $1.9 million in 2021, then soared by 104.38% to $4.0 million in 2022, then surged by 74.72% to $6.9 million in 2023, then rose by 19.98% to $8.3 million in 2024.
  • Its Long-Term Deferred Tax was $8.3 million in Q4 2024, compared to $6.9 million in Q4 2023 and $5.4 million in Q3 2023.